Norbert Kraut

10PUBLICATIONS
105CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 15, 2026
Therapeutic targeting of β-catenin in cancer.

|Apr 19, 2026
A Roadmap to Transform Lung Cancer Outcomes: Priorities in Biology, Therapeutic Innovation, Early Detection, Prevention, and Interception.

|Dec 23, 2024
Pan-KRAS Inhibitors BI-2493 and BI-2865 Display Potent Antitumor Activity in Tumors with KRAS Wild-type Allele Amplification.

Antonio Tedeschi, Fiorella Schischlik, Francesca Rocchetti

|Sep 11, 2024
Discovery and Characterization of Brigimadlin, a Novel and Highly Potent MDM2-p53 Antagonist Suitable for Intermittent Dose Schedules.

Andreas Gollner, Dorothea Rudolph, Ulrike Weyer-Czernilofsky

|Sep 09, 2024
Zongertinib (BI 1810631), an Irreversible HER2 TKI, Spares EGFR Signaling and Improves Therapeutic Response in Preclinical Models and Patients with HER2-Driven Cancers.

Birgit Wilding, Lydia Woelflingseder, Anke Baum

|Aug 05, 2024
Co-targeting SOS1 enhances the antitumor effects of KRASG12C inhibitors by addressing intrinsic and acquired resistance.

Venu Thatikonda, Hengyu Lyu, Sabine Jurado

Pageof 2

Frequent Collaborators

6 joint publications

Daniel Gerlach

3 joint publications

Marco H Hofmann

3 joint publications

Darryl B McConnell

2 joint publications

Johannes Popow